(Q41149840)

English

Mathematical Examination of Dual Individualization Principles (I): Relationships between AUC above MIC and Area under the Inhibitory Curve for Cefmenoxime, Ciprofloxacin, and Tobramycin

scientific article published on October 1, 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Mathematical Examination of Dual Individualization Principles (I): Relationships between AUC above MIC and Area under the Inhibitory Curve for Cefmenoxime, Ciprofloxacin, and Tobramycin (English)

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

mathematical model

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1803788

29 November 2022

author name string

J. J. Schentag

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1803788

29 November 2022

D. E. Nix

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1803788

29 November 2022

M. H. Adelman

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1803788

29 November 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1803788

29 November 2022

publication date

1 October 1991

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

full work available at URL

http://journals.sagepub.com/doi/pdf/10.1177/106002809102501003

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

DICP : the annals of pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

1050-1057

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

1

48

513

author name string

Dalton HP

publication date

1982

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

The inhibitory quotient. A method for interpreting minimum inhibitory concentration data

5

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

Clinical pharmacy

6

2

448

author name string

Schumacher GE

publication date

1983

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

Integration of pharmacokinetics and pharmacodynamics of methicillin in curative treatment of experimental endocarditis

7

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models

8

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

The importance of pharmacodynamics in determining the dosing interval in therapy for experimental pseudomonas endocarditis in the rat

9

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

Simultaneous antibiotic levels in "breakthrough" gram-negative rod bacteremia

10

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

Factors associated with nephrotoxicity and clinical outcome in patients receiving amikacin

11

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

Role for Dual Individualization with Cefmenoxime

12

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

Dual individualization: antibiotic dosage calculation from the integration of in-vitro pharmacodynamics and in-vivo pharmacokinetics

14

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

Analysis of a new method for assessing activity of combinations of antimicrobials: area under the bactericidal activity curve

15

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

Drug therapy. Serum bactericidal activity as a monitor of antibiotic therapy

16

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

Correlation of serum bactericidal activity with antimicrobial agent level and minimal bactericidal concentration

17

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

Correlation of predicted serum bactericidal activities and values measured in volunteers.

18

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

Use of serum ultrafiltrate in the serum dilution test

20

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

Perspective: the serum dilution test

21

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

Laboratory tests for defining bactericidal activity as predictors of antibiotic efficacy in the treatment of endocarditis due to Staphylococcus aureus in rabbits

22

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

Multicenter collaborative evaluation of a standardized serum bactericidal test as a prognostic indicator in infective endocarditis

23

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

Drug Intelligence & Clinical Pharmacy

24

21

187

author name string

McCormack JP

publication date

1987

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

25

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

Absence of a postantibiotic effect in experimental Pseudomonas endocarditis treated with imipenem, with or without gentamicin.

26

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

Postantibiotic effect of penicillin plus gentamicin versus Enterococcus faecalis in vitro and in vivo

27

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

Resistance occurring after fluoroquinolone therapy of experimental Pseudomonas aeruginosa peritonitis

28

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

Continuous versus intermittent administration of ceftazidime in experimental Klebsiella pneumoniae pneumonia in normal and leukopenic rats

30

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model

31

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

Treatment with aztreonam or tobramycin in critical care patients with nosocomial gram-negative pneumonia

32

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

Clinical pharmacy

33

5

319

author name string

Deziel-Evans LM

publication date

1986

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis

34

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

Role of pharmacokinetics in the outcome of infections

35

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

Integration of Selected Pharmacologic and Microbiologic Properties of Three New -Lactam Antibiotics: A Hypothesis for Rational Comparison

36

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

Effect of extracellular water volume on the distribution kinetics of beta-lactam antibiotics as a function of age.

37

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

Effect of the ratio of surface area to volume on the penetration of antibiotics in to extravascular spaces in an in vitro model

38

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

Gentamicin and tobramycin dosing guidelines: an evaluation

41

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

Cefmenoxime Efficacy, Safety, and Pharmacokinetics in Critical Care Patients with Nosocomial Pneumonia

42

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

Antibiotic Penetration in Abdominal Infection: A Case of Tobramycin Failure Responsive to Moxalactam

44

1 reference

10.1177/106002809102501003

https://api.crossref.org/works/10.1177/106002809102501003

29 November 2022

Identifiers

10.1177/106002809102501003

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1803788

29 November 2022

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41149840&oldid=2076221916"